As reviewed in Part 3, LambdaVision, based in Farmington, Connecticut, USA, was founded in 2009 by its President and CEO Dr. Nicole Wagner and co-founder chemist Jordan Greco. Dr. Robert Birge, distinguished chair in chemistry at the University of Connecticut, a renowned expert in the incorporation of light-activated proteins into biomolecular electronic and therapeutic applications, is a Member of the Board of Directors of the company.
